Ashleigh Shannon

1.3k total citations
16 papers, 673 citations indexed

About

Ashleigh Shannon is a scholar working on Molecular Biology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ashleigh Shannon has authored 16 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ashleigh Shannon's work include SARS-CoV-2 and COVID-19 Research (7 papers), Mosquito-borne diseases and control (5 papers) and HIV Research and Treatment (3 papers). Ashleigh Shannon is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Mosquito-borne diseases and control (5 papers) and HIV Research and Treatment (3 papers). Ashleigh Shannon collaborates with scholars based in France, United States and Australia. Ashleigh Shannon's co-authors include Bruno Canard, Étienne Decroly, Thi-Tuyet-Nhung Le, François Ferrón, Barbara Selisko, Olve B. Peersen, Jean‐Claude Guillemot, Cécilia Eydoux, Karine Alvarez and Franck Touret and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Virology.

In The Last Decade

Ashleigh Shannon

16 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashleigh Shannon France 10 487 177 93 79 77 16 673
Jennifer Gribble United States 6 479 1.0× 135 0.8× 50 0.5× 30 0.4× 101 1.3× 7 584
Emma Woolner Canada 4 682 1.4× 207 1.2× 135 1.5× 26 0.3× 72 0.9× 6 847
Calli M. Lear-Rooney United States 8 707 1.5× 229 1.3× 129 1.4× 87 1.1× 223 2.9× 8 1.0k
Gregory R. Bluemling United States 10 663 1.4× 179 1.0× 56 0.6× 115 1.5× 320 4.2× 15 901
Lucía Barrado-Gil Spain 12 320 0.7× 163 0.9× 160 1.7× 34 0.4× 67 0.9× 16 746
Ilaria Vicenti Italy 19 670 1.4× 123 0.7× 71 0.8× 140 1.8× 222 2.9× 75 943
Ana Shulla United States 8 581 1.2× 314 1.8× 82 0.9× 94 1.2× 147 1.9× 8 1.0k
Ulrik Fahnøe Denmark 17 494 1.0× 184 1.0× 109 1.2× 57 0.7× 303 3.9× 71 1.0k
Florian Kabinger Germany 3 363 0.7× 136 0.8× 76 0.8× 17 0.2× 99 1.3× 3 481
Thi-Tuyet-Nhung Le France 7 610 1.3× 254 1.4× 112 1.2× 15 0.2× 89 1.2× 14 811

Countries citing papers authored by Ashleigh Shannon

Since Specialization
Citations

This map shows the geographic impact of Ashleigh Shannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh Shannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh Shannon more than expected).

Fields of papers citing papers by Ashleigh Shannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashleigh Shannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh Shannon. The network helps show where Ashleigh Shannon may publish in the future.

Co-authorship network of co-authors of Ashleigh Shannon

This figure shows the co-authorship network connecting the top 25 collaborators of Ashleigh Shannon. A scholar is included among the top collaborators of Ashleigh Shannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashleigh Shannon. Ashleigh Shannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Selisko, Barbara, Véronique Fattorini, Géraldine Piorkowski, et al.. (2024). The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymerase. Antiviral Research. 232. 106034–106034. 3 indexed citations
2.
Shannon, Ashleigh & Bruno Canard. (2024). Nucleotide analogues and mpox: Repurposing the repurposable. Antiviral Research. 234. 106057–106057. 4 indexed citations
3.
Shannon, Ashleigh, Mikaël Feracci, Véronique Fattorini, et al.. (2023). An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex. Nucleic Acids Research. 52(3). 1325–1340. 6 indexed citations
4.
Shannon, Ashleigh, Théo Guez, Françoise Debart, et al.. (2022). A second type of N7-guanine RNA cap methyltransferase in an unusual locus of a large RNA virus genome. Nucleic Acids Research. 50(19). 11186–11198. 4 indexed citations
5.
Shannon, Ashleigh & Bruno Canard. (2022). Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2. Antiviral Research. 210. 105501–105501. 23 indexed citations
6.
Bera, Subhas Chandra, Pauline van Nies, Robert N. Kirchdoerfer, et al.. (2021). Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. eLife. 10. 51 indexed citations
7.
Good, Steven S., Ashleigh Shannon, Kai Lin, et al.. (2021). Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses. Antimicrobial Agents and Chemotherapy. 65(11). e0098821–e0098821. 31 indexed citations
8.
Valle, Coralie, Ashleigh Shannon, Étienne Decroly, et al.. (2021). Structure and Sequence Requirements for RNA Capping at the Venezuelan Equine Encephalitis Virus RNA 5′ End. Journal of Virology. 95(15). e0077721–e0077721. 3 indexed citations
9.
Shannon, Ashleigh, Barbara Selisko, Thi-Tuyet-Nhung Le, et al.. (2020). Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nature Communications. 11(1). 4682–4682. 199 indexed citations
10.
Eydoux, Cécilia, Véronique Fattorini, Ashleigh Shannon, et al.. (2020). A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex. Journal of Virological Methods. 288. 114013–114013. 13 indexed citations
11.
Shannon, Ashleigh, Thi-Tuyet-Nhung Le, Barbara Selisko, et al.. (2020). Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Research. 178. 104793–104793. 235 indexed citations
12.
Valle, Coralie, Baptiste Martin, Franck Touret, et al.. (2020). Drugs against SARS‐CoV‐2: What do we know about their mode of action?. Reviews in Medical Virology. 30(6). 1–10. 32 indexed citations
13.
Ferrón, François, Humberto Debat, Ashleigh Shannon, Étienne Decroly, & Bruno Canard. (2019). A N7-guanine RNA cap methyltransferase signature-sequence as a genetic marker of large genome, non-mammalian Tobaniviridae. NAR Genomics and Bioinformatics. 2(1). lqz022–lqz022. 9 indexed citations
14.
Muller, David A., Alexandra C. I. Depelsenaire, Ashleigh Shannon, et al.. (2019). Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays. Vaccines. 7(4). 189–189. 27 indexed citations
15.
Shannon, Ashleigh, Marcelo Monteiro Pedroso, Keith J. Chappell, et al.. (2016). Product release is rate-limiting for catalytic processing by the Dengue virus protease. Scientific Reports. 6(1). 37539–37539. 13 indexed citations
16.
Shannon, Ashleigh, Keith J. Chappell, Martin J. Stoermer, et al.. (2015). Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain. Protein Expression and Purification. 119. 124–129. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Gribble Breakdown of academic impact, for papers by Emma Woolner Breakdown of academic impact, for papers by Calli M. Lear-Rooney Breakdown of academic impact, for papers by Gregory R. Bluemling Breakdown of academic impact, for papers by Lucía Barrado-Gil Breakdown of academic impact, for papers by Ilaria Vicenti Breakdown of academic impact, for papers by Ana Shulla Breakdown of academic impact, for papers by Ulrik Fahnøe Breakdown of academic impact, for papers by Florian Kabinger Breakdown of academic impact, for papers by Thi-Tuyet-Nhung Le
Rankless by CCL
2026